ESR2 and ovarian carcinoma: It has previously been reported that ERβ mediates ovarian cancer cell growth repression by decreasing the cellular content of, among others, retinoblastoma, phospho-AKT, cyclin D1, and A2 as well as upregulating the cyclin-dependent kinase inhibitor p2113,14,26, 27.